Tisha buys CLVS 44.22: Clovis Oncology Coverage Initiated by Analysts at Leerink Swann (CLVS)
Stock analysts at Leerink Swann initiated coverage on shares of Clovis Oncology (NASDAQ:CLVS) in a report issued on Friday. The firm set an âoutperformâ rating and a $100.00 price target on the stock. Leerink Swannâs price target points to a ... ...
28 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home